Circulating Small Extracellular Vesicles Reflect the Severity of Myocardial Damage in STEMI Patients

Area of Science:

• Cardiology
• Biomedical Engineering
• Vascular Biology

Background:

• Small extracellular vesicles (sEVs) are implicated in inflammation, coagulation, and vascular injury.
• sEVs show promise as diagnostic markers for various diseases.
• The relationship between sEVs and myocardial damage in ST-segment elevation myocardial infarction (STEMI) is not well understood.

Purpose of the Study:

• To investigate the association between plasma sEV characteristics and myocardial damage assessed by Cardiac Magnetic Resonance (CMR) in STEMI patients.
• To determine if sEVs can serve as biomarkers for myocardial injury and microvascular obstruction post-STEMI.

Main Methods:

• Plasma sEVs were isolated from 42 STEMI patients treated with primary percutaneous coronary intervention (pPCI).
• sEVs were analyzed using Nanoparticle Tracking Analysis (NTA).
• Cardiac Magnetic Resonance (CMR) was performed to assess myocardial damage, microvascular obstruction (MVO), and myocardial salvage index (MSI).

Main Results:

• Larger sEV size was observed in anterior STEMI, culprit lesions in LAD, and late revascularization.
• Smaller sEV size correlated with lower MSI and the presence of MVO.
• Lower expression of the platelet marker CD41-CD61 on sEVs was associated with MVO.
• sEV size and CD41-CD61 expression independently predicted MVO/MSI.

Conclusions:

• CD41-CD61 expression on circulating sEVs reflects CMR-assessed ischemic damage in STEMI patients.
• sEV characteristics, particularly CD41-CD61 expression, may aid in identifying high-risk STEMI patients.
• This research supports the development of sEV-based strategies for timely patient risk stratification and treatment optimization.